Incomplete or weak documentation may lead to delays or denials. Laboratory effects and diagnostic stories can also be essential, especially if fundamental conditions support the need for Zepbound. Blood assessments demonstrating irregular glucose concentrations, lipid profiles, or other metabolic markers can reinforce the argument. If prior treatme